Literature DB >> 23229043

β-amyloid dynamics in human plasma.

Yafei Huang, Rachel Potter, Wendy Sigurdson, Tom Kasten, Rose Connors, John C Morris, Tammie Benzinger, Mark Mintun, Tim Ashwood, Mats Ferm, Samantha L Budd, Randall J Bateman.   

Abstract

OBJECTIVES: To investigate dynamic changes in human plasma β-amyloid (Aβ) concentrations, evaluate the effects of aging and amyloidosis on these dynamics, and determine their correlation with cerebrospinal fluid (CSF) Aβ concentrations.
DESIGN: A repeated plasma and CSF sampling study.
SETTING: The Washington University School of Medicine in St Louis, Missouri. PARTICIPANTS: Older adults with amyloid deposition (Amyloid+), age-matched controls without amyloid deposition (Amyloid-), and younger normal controls (YNCs) were enrolled for the study. MAIN OUTCOME MEASURES: Hourly measurements of plasma Aβ were compared between groups by age and amyloidosis. Plasma Aβ and CSF Aβ concentrations were compared for correlation, linear increase, and circadian patterns.
RESULTS: Circadian patterns were observed in plasma Aβ, with diminished amplitudes with aging. Linear increase of Aβ was only observed for CSF Aβ in the YNC and Amyloid- groups, but not in the Amyloid+ group. No linear increase was observed for plasma Aβ. No significant correlations were found between plasma and CSF Aβ concentrations.
CONCLUSIONS: Plasma Aβ, like CSF, demonstrates a circadian pattern that is reduced in amplitude with increasing age but is unaffected by amyloid deposition. However, we found no evidence that plasma and CSF Aβ concentrations were related on an hourly or individual basis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229043      PMCID: PMC3808092          DOI: 10.1001/archneurol.2012.18107

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  22 in total

1.  Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

Authors:  N Andreasen; C Hesse; P Davidsson; L Minthon; A Wallin; B Winblad; H Vanderstichele; E Vanmechelen; K Blennow
Journal:  Arch Neurol       Date:  1999-06

2.  [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.

Authors:  M A Mintun; G N Larossa; Y I Sheline; C S Dence; S Y Lee; R H Mach; W E Klunk; C A Mathis; S T DeKosky; J C Morris
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

3.  Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid.

Authors:  Stephen D Weigand; Prashanthi Vemuri; Heather J Wiste; Matthew L Senjem; Vernon S Pankratz; Paul S Aisen; Michael W Weiner; Ronald C Petersen; Leslie M Shaw; John Q Trojanowski; David S Knopman; Clifford R Jack
Journal:  Alzheimers Dement       Date:  2011-02-01       Impact factor: 21.566

4.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Authors:  Anne M Fagan; Mark A Mintun; Robert H Mach; Sang-Yoon Lee; Carmen S Dence; Aarti R Shah; Gina N LaRossa; Michael L Spinner; William E Klunk; Chester A Mathis; Steven T DeKosky; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

5.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

6.  Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers.

Authors:  Diane Slats; Jurgen A H R Claassen; Petra E Spies; George Borm; Kees T C Besse; William van Aalst; Jack Tseng; Magnus J C Sjögren; Marcel G M Olde Rikkert; Marcel M Verbeek
Journal:  Neurobiol Aging       Date:  2011-08-31       Impact factor: 4.673

7.  Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline.

Authors:  Kristine Yaffe; Andrea Weston; Neill R Graff-Radford; Suzanne Satterfield; Eleanor M Simonsick; Steven G Younkin; Linda H Younkin; Lewis Kuller; Hilsa N Ayonayon; Jingzhong Ding; Tamara B Harris
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

8.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Authors:  D Galasko; L Chang; R Motter; C M Clark; J Kaye; D Knopman; R Thomas; D Kholodenko; D Schenk; I Lieberburg; B Miller; R Green; R Basherad; L Kertiles; M A Boss; P Seubert
Journal:  Arch Neurol       Date:  1998-07
View more
  30 in total

Review 1.  Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.

Authors:  Md Sahab Uddin; Dewan Md Sumsuzzman; Philippe Jeandet; Tapan Behl; Abdur Rauf; Md Shah Amran; Ghulam Md Ashraf
Journal:  Neurochem Res       Date:  2021-04-19       Impact factor: 3.996

Review 2.  Circadian regulation of membrane physiology in neural oscillators throughout the brain.

Authors:  Jodi R Paul; Jennifer A Davis; Lacy K Goode; Bryan K Becker; Allison Fusilier; Aidan Meador-Woodruff; Karen L Gamble
Journal:  Eur J Neurosci       Date:  2019-01-29       Impact factor: 3.386

Review 3.  The sleep-wake cycle and Alzheimer's disease: what do we know?

Authors:  Miranda M Lim; Jason R Gerstner; David M Holtzman
Journal:  Neurodegener Dis Manag       Date:  2014

4.  Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.

Authors:  Ricardo S Osorio; Indu Ayappa; Janna Mantua; Tyler Gumb; Andrew Varga; Anne M Mooney; Omar E Burschtin; Zachary Taxin; Emmanuel During; Nicole Spector; Milton Biagioni; Elizabeth Pirraglia; Hiuyan Lau; Henrik Zetterberg; Kaj Blennow; Shou-En Lu; Lisa Mosconi; Lidia Glodzik; David M Rapoport; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

5.  Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice.

Authors:  Miguel Pappolla; Kumar Sambamurti; Ruben Vidal; Javier Pacheco-Quinto; Burkhard Poeggeler; Etsuro Matsubara
Journal:  Neurobiol Dis       Date:  2014-08-04       Impact factor: 5.996

6.  Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer's disease and dementia not due to Alzheimer's disease.

Authors:  Jonathan Vogelgsang; Hedieh Shahpasand-Kroner; Rebekka Vogelgsang; Frank Streit; Ruth Vukovich; Jens Wiltfang
Journal:  Exp Brain Res       Date:  2018-02-26       Impact factor: 1.972

Review 7.  Consequences of Circadian Disruption on Neurologic Health.

Authors:  Aleksandar Videnovic; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2015-09-26

Review 8.  Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis.

Authors:  Kenia Kelly Fiaux do Nascimento; Kelly P Silva; Leandro F Malloy-Diniz; Meryl A Butters; Breno S Diniz
Journal:  J Psychiatr Res       Date:  2015-07-26       Impact factor: 4.791

Review 9.  Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.

Authors:  Ashvini Keshavan; Amanda Heslegrave; Henrik Zetterberg; Jonathan M Schott
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

10.  Autonomic Modulation During Baseline and Recovery Sleep in Adult Sleepwalkers.

Authors:  Geneviève Scavone; Andrée-Ann Baril; Jacques Montplaisir; Julie Carrier; Alex Desautels; Antonio Zadra
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.